Jeffrey S. Buguliskis on Muck Rack

Jeffrey S. Buguliskis

New York
As seen in: Life Science Connect, Industrial Biotechnology, Genetic Engineering & Biotechnology News, SynBioBeta, Inside Precision Medicine, Bioprocess Online, Outsourced Pharma, Cell & Gene, Biosimilar Development, Advancing RNA
Molecular Parasitologist, Science Educator, Director of Content @SynBioBeta, Philly Transplant, Go Birds! Go Phils!

Get in touch with Jeffrey S.

Contact Jeffrey S., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Oligonucleotide Scale-Up: Six Things Every Sponsor Needs To Know

|
By Jeffrey S. Buguliskis, Louis Garguilo Verified
| Outsourced Pharma
By Jeffrey S. Buguliskis, PhD, Deputy Chief Editor, Outsourced Pharma There is a phase in every promising technology when the science is genuinely thrilling, serious money is flowing in, and then suddenly everyone you meet claims they have decades of relevant experience working with it. Oligonucleotides are in that phase right now, and this should make you both hopeful and deeply suspicious. Now, the hope is understandable.
Open in Who Shared Issue with article?

06.08.26 -- BIOSECURE Act And The 8 Supply-Chain Lessons Sponsors Can't Ignore

|
By Jeffrey S. Buguliskis, Kevin Hickman, Louis Garguilo Verified
| Outsourced Pharma
Selecting The Right Technology For Early Drug Development Assimilate how selecting the right solubility‑enhancing technology improves early exposure, supports flexible dosing, and lays a strong foundation for downstream oral drug development. Should Biotech Companies Partner, Sell, Or License Their Technology?
Open in Who Shared Issue with article?

BIOSECURE Act And The 8 Supply-Chain Lessons Sponsors Can't Ignore

|
By Jeffrey S. Buguliskis, Louis Garguilo Verified
| Outsourced Pharma
Get more pharma outsourcing insight with our FREE newsletter From The Editor | May 26, 2026 By Jeffrey S. Buguliskis, PhD, Deputy Chief Editor, Outsourced Pharma A supply chain is less like a chain than a root system. Some roots are thick and visible: the primary CDMO, the lead analytical lab, and the preferred supplier. In contrast, others are fine as hair and buried deep: a reagent, a subcontracted test, a data handoff, an affiliate, or a backup site that was never truly independent.
Open in Who Shared Issue with article?
See all 650 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified